Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Datavault AI stock jumps premarket as DVLT traders focus on Jan. 7 warrant dividend clock

Datavault AI stock jumps premarket as DVLT traders focus on Jan. 7 warrant dividend clock

Datavault AI Inc shares jumped 22.7% to $0.80 in premarket trading Friday ahead of a Jan. 7 record date for proposed warrant and token dividends. Top holder Scilex reported it still owns 42.6% after selling 20.7 million shares last week. About 274,000 shares traded premarket. Warrants will require holders to also own a Dream Bowl Meme Coin II token in a Datavault wallet.
2 January 2026
·
Bitmine stock slips in premarket as crypto-linked shares ease into 2026

Bitmine stock slips in premarket as crypto-linked shares ease into 2026

Bitmine Immersion Technologies shares fell about 2% to $27.15 in early premarket trading Friday, even as bitcoin and ether rose. Investors are watching Bitmine’s January 15 annual meeting in Las Vegas, where shareholders will vote on board seats and key proposals. The company reported holding over 4.1 million ether, 192 bitcoin, and $1 billion in cash as of December 28. Several other crypto-linked stocks also traded lower premarket.
2 January 2026
··
UK energy bills forecast to drop £138 in April 2026 after levy shake-up

UK energy bills forecast to drop £138 in April 2026 after levy shake-up

Cornwall Insight forecasts the UK energy price cap will drop 8% in April, lowering a typical annual dual-fuel bill to about £1,620. Ofgem’s cap for Jan.–Mar. rose 0.2% to £1,758, driven by higher policy and supplier costs. The April cut is linked to budget changes moving some levies to general taxation. Wholesale prices have eased, but some network charges are still set to rise.
2 January 2026
·
IREN stock rises in premarket as bitcoin rebounds — what traders are watching

IREN stock rises in premarket as bitcoin rebounds — what traders are watching

IREN Limited shares rose 3.1% to $38.95 in premarket trading Friday, tracking bitcoin’s 1.6% climb to $89,034. The stock, valued at $10.9 billion, traded between $37.20 and $39.03 in the previous session. Other U.S.-listed miners were mixed. Traders are watching bitcoin’s $90,000 level and IREN’s next earnings report on Feb. 11.
2 January 2026
······
Baidu stock in focus as Kunlunxin Hong Kong listing plan lands — and Jefferies lifts target

Baidu stock in focus as Kunlunxin Hong Kong listing plan lands — and Jefferies lifts target

Baidu filed a confidential application to list its AI chip unit Kunlunxin in Hong Kong as part of a planned spin-off. Baidu’s Hong Kong shares rose 7.5% to HK$141.30, while its U.S.-listed shares last closed at $130.66, down 1.3%. The company said the deal is not finalized and would require regulatory approvals. Investors await details on deal structure and potential impact on U.S. trading.
2 January 2026
··
Pitney Bowes NT 43 drops 3% today as Treasury yields rise — what’s next for PBI.PRB

Pitney Bowes NT 43 (PBI-PB) slides 6% into year-end — what investors are watching next

NEW YORK, January 1, 2026, 11:00 ET — Market closed Pitney Bowes Inc. NT 43 (PBI-PB) fell $1.30, or 5.99%, to $20.39 in the final trading session of 2025, after swinging between $21.99 and $20.28 on volume of 583,343. U.S. markets are closed on Thursday for the New Year’s Day holiday. StockAnalysis The move matters because “NT 43” is not common equity — it is exchange-traded debt, meaning it trades like a stock but represents a loan to the company. These securities can gap on shifts in interest-rate expectations and on changes in how much risk investors want to hold.
1 January 2026
·
Corcept Therapeutics (CORT) stock sinks after FDA rebuff; relacorilant outlook resets

Corcept Therapeutics (CORT) stock sinks after FDA rebuff; relacorilant outlook resets

Corcept shares closed down 50.4% at $34.80 after the FDA declined to approve relacorilant for Cushing’s-related hypertension, citing insufficient evidence. Truist cut its price target to $50 and Wolfe downgraded the stock to Underperform with a $30 target. The FDA set a July 11, 2026 decision date for relacorilant in ovarian cancer. U.S. markets are closed Thursday for New Year’s Day.
1 January 2026
··
ICL stock today: ICL Group ends 2025 up 3% as China potash contracts shape the 2026 view

ICL stock today: ICL Group ends 2025 up 3% as China potash contracts shape the 2026 view

ICL Group shares closed up 3.0% at $5.71 on Wednesday, with U.S. markets shut Thursday for New Year’s Day. The company recently signed contracts to supply 750,000 metric tons of potash to China in 2026 at $348 per ton. Retail potash prices tracked by DTN stood at $484 per ton in late December, up 9% from a year earlier. Trading volume reached 1.86 million shares, more than double the average.
1 January 2026
·
BTDR stock today: Bitdeer closes up 3% into year-end as bitcoin weakens — what traders watch next

BTDR stock today: Bitdeer closes up 3% into year-end as bitcoin weakens — what traders watch next

Bitdeer Technologies Group shares closed up 3.3% at $11.21 on Dec. 31, outpacing other U.S.-listed bitcoin miners. Bitcoin was last down 0.5% near $87,800. Investors are watching a Feb. 2 deadline in a securities class action alleging Bitdeer misled shareholders about its SEALMINER roadmap and chip delays. The company reported a $266.7 million net loss in its Nov. 10 results.
1 January 2026
···
1 … 275 276 277 278 279 … 535

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
LONDON, Feb 7, 2026, 20:00 GMT — Market closed AstraZeneca PLC (AZN) heads into next week’s trading with its New York-listed shares closing on Friday up 3.1% at $193.03, after-hours up a further 0.7% to $194.40. (Yahoo Finance) With markets shut on Saturday, the focus is Tuesday’s full-year and fourth-quarter 2025 report, which AstraZeneca said it will publish at 07:00 GMT, followed by an investor webcast at 11:45 GMT. (AstraZeneca) This matters now because the stock has drifted into earnings with little fresh company news on Friday itself, leaving guidance to do more of the heavy lifting. For AstraZeneca, the
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop